R-Cinex E (Isoniazid/Rifampicin/Ethambutol)
| Active Ingredient | Isoniazid/Rifampicin/Ethambutol |
|---|---|
| Indication: | Tuberculosis (TB) |
| Manufacturer: | Lupin Limited |
| Packaging | 6 Tablets in 1 Strip |
| Strength | 300mg/450mg/800mg |
| Delivery Time | 6 To 15 days |
R-Cinex E is a fixed-dose combination anti-tuberculosis medication containing Isoniazid, Rifampicin, and Ethambutol—three first-line drugs used in the treatment of active tuberculosis (TB). It is primarily prescribed during the initial or continuation phases of TB treatment as part of a multi-drug regimen to effectively eliminate Mycobacterium tuberculosis and prevent drug resistance.
Isoniazid inhibits mycolic acid synthesis, essential for bacterial cell wall formation.
Rifampicin blocks RNA synthesis, effectively killing active bacteria.
Ethambutol interferes with cell wall metabolism and helps prevent resistance to other drugs.
R-Cinex E ensures high treatment compliance by reducing the number of pills patients need to take daily. It is typically administered under national TB programs such as DOTS (Directly Observed Treatment, Short-course).








There are no reviews yet.